Lung Cancer Therapeutics and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Lung Cancer Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Lung Cancer Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Lung Cancer Therapeutics Overall Market Size
2.1 Global Lung Cancer Therapeutics Market Size: 2021 VS 2028
2.2 Global Lung Cancer Therapeutics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Lung Cancer Therapeutics Players in Global Market
3.2 Top Global Lung Cancer Therapeutics Companies Ranked by Revenue
3.3 Global Lung Cancer Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Lung Cancer Therapeutics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Lung Cancer Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Lung Cancer Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Lung Cancer Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Lung Cancer Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Lung Cancer Therapeutics Market Size Markets, 2021 & 2028
4.1.2 Targeted Therapy
4.1.3 Immunotherapy
4.1.4 Chemotherapy
4.1.5 Radiation Therapy
4.1.6 Others
4.2 By Type - Global Lung Cancer Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Lung Cancer Therapeutics Revenue, 2017-2022
4.2.2 By Type - Global Lung Cancer Therapeutics Revenue, 2023-2028
4.2.3 By Type - Global Lung Cancer Therapeutics Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Lung Cancer Therapeutics Market Size, 2021 & 2028
5.1.2 Non-Small Cell Lung Cancer (NSCLC)
5.1.3 Small Cell Lung Cancer (SCLC)
5.2 By Application - Global Lung Cancer Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Lung Cancer Therapeutics Revenue, 2017-2022
5.2.2 By Application - Global Lung Cancer Therapeutics Revenue, 2023-2028
5.2.3 By Application - Global Lung Cancer Therapeutics Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Lung Cancer Therapeutics Market Size, 2021 & 2028
6.2 By Region - Global Lung Cancer Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Lung Cancer Therapeutics Revenue, 2017-2022
6.2.2 By Region - Global Lung Cancer Therapeutics Revenue, 2023-2028
6.2.3 By Region - Global Lung Cancer Therapeutics Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Lung Cancer Therapeutics Revenue, 2017-2028
6.3.2 US Lung Cancer Therapeutics Market Size, 2017-2028
6.3.3 Canada Lung Cancer Therapeutics Market Size, 2017-2028
6.3.4 Mexico Lung Cancer Therapeutics Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Lung Cancer Therapeutics Revenue, 2017-2028
6.4.2 Germany Lung Cancer Therapeutics Market Size, 2017-2028
6.4.3 France Lung Cancer Therapeutics Market Size, 2017-2028
6.4.4 U.K. Lung Cancer Therapeutics Market Size, 2017-2028
6.4.5 Italy Lung Cancer Therapeutics Market Size, 2017-2028
6.4.6 Russia Lung Cancer Therapeutics Market Size, 2017-2028
6.4.7 Nordic Countries Lung Cancer Therapeutics Market Size, 2017-2028
6.4.8 Benelux Lung Cancer Therapeutics Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Lung Cancer Therapeutics Revenue, 2017-2028
6.5.2 China Lung Cancer Therapeutics Market Size, 2017-2028
6.5.3 Japan Lung Cancer Therapeutics Market Size, 2017-2028
6.5.4 South Korea Lung Cancer Therapeutics Market Size, 2017-2028
6.5.5 Southeast Asia Lung Cancer Therapeutics Market Size, 2017-2028
6.5.6 India Lung Cancer Therapeutics Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Lung Cancer Therapeutics Revenue, 2017-2028
6.6.2 Brazil Lung Cancer Therapeutics Market Size, 2017-2028
6.6.3 Argentina Lung Cancer Therapeutics Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Lung Cancer Therapeutics Revenue, 2017-2028
6.7.2 Turkey Lung Cancer Therapeutics Market Size, 2017-2028
6.7.3 Israel Lung Cancer Therapeutics Market Size, 2017-2028
6.7.4 Saudi Arabia Lung Cancer Therapeutics Market Size, 2017-2028
6.7.5 UAE Lung Cancer Therapeutics Market Size, 2017-2028
7 Players Profiles
7.1 AstraZeneca
7.1.1 AstraZeneca Corporate Summary
7.1.2 AstraZeneca Business Overview
7.1.3 AstraZeneca Lung Cancer Therapeutics Major Product Offerings
7.1.4 AstraZeneca Lung Cancer Therapeutics Revenue in Global Market (2017-2022)
7.1.5 AstraZeneca Key News
7.2 Eli Lilly and Company
7.2.1 Eli Lilly and Company Corporate Summary
7.2.2 Eli Lilly and Company Business Overview
7.2.3 Eli Lilly and Company Lung Cancer Therapeutics Major Product Offerings
7.2.4 Eli Lilly and Company Lung Cancer Therapeutics Revenue in Global Market (2017-2022)
7.2.5 Eli Lilly and Company Key News
7.3 GlaxoSmithKline
7.3.1 GlaxoSmithKline Corporate Summary
7.3.2 GlaxoSmithKline Business Overview
7.3.3 GlaxoSmithKline Lung Cancer Therapeutics Major Product Offerings
7.3.4 GlaxoSmithKline Lung Cancer Therapeutics Revenue in Global Market (2017-2022)
7.3.5 GlaxoSmithKline Key News
7.4 Roche
7.4.1 Roche Corporate Summary
7.4.2 Roche Business Overview
7.4.3 Roche Lung Cancer Therapeutics Major Product Offerings
7.4.4 Roche Lung Cancer Therapeutics Revenue in Global Market (2017-2022)
7.4.5 Roche Key News
7.5 Boehringer Ingelheim GmbH
7.5.1 Boehringer Ingelheim GmbH Corporate Summary
7.5.2 Boehringer Ingelheim GmbH Business Overview
7.5.3 Boehringer Ingelheim GmbH Lung Cancer Therapeutics Major Product Offerings
7.5.4 Boehringer Ingelheim GmbH Lung Cancer Therapeutics Revenue in Global Market (2017-2022)
7.5.5 Boehringer Ingelheim GmbH Key News
7.6 Pfizer
7.6.1 Pfizer Corporate Summary
7.6.2 Pfizer Business Overview
7.6.3 Pfizer Lung Cancer Therapeutics Major Product Offerings
7.6.4 Pfizer Lung Cancer Therapeutics Revenue in Global Market (2017-2022)
7.6.5 Pfizer Key News
7.7 Sanofi S.A.
7.7.1 Sanofi S.A. Corporate Summary
7.7.2 Sanofi S.A. Business Overview
7.7.3 Sanofi S.A. Lung Cancer Therapeutics Major Product Offerings
7.7.4 Sanofi S.A. Lung Cancer Therapeutics Revenue in Global Market (2017-2022)
7.7.5 Sanofi S.A. Key News
7.8 Bristol-Myers Squibb
7.8.1 Bristol-Myers Squibb Corporate Summary
7.8.2 Bristol-Myers Squibb Business Overview
7.8.3 Bristol-Myers Squibb Lung Cancer Therapeutics Major Product Offerings
7.8.4 Bristol-Myers Squibb Lung Cancer Therapeutics Revenue in Global Market (2017-2022)
7.8.5 Bristol-Myers Squibb Key News
7.9 Novartis
7.9.1 Novartis Corporate Summary
7.9.2 Novartis Business Overview
7.9.3 Novartis Lung Cancer Therapeutics Major Product Offerings
7.9.4 Novartis Lung Cancer Therapeutics Revenue in Global Market (2017-2022)
7.9.5 Novartis Key News
7.10 Agennix AG
7.10.1 Agennix AG Corporate Summary
7.10.2 Agennix AG Business Overview
7.10.3 Agennix AG Lung Cancer Therapeutics Major Product Offerings
7.10.4 Agennix AG Lung Cancer Therapeutics Revenue in Global Market (2017-2022)
7.10.5 Agennix AG Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Lung Cancer Therapeutics Market Opportunities & Trends in Global Market
Table 2. Lung Cancer Therapeutics Market Drivers in Global Market
Table 3. Lung Cancer Therapeutics Market Restraints in Global Market
Table 4. Key Players of Lung Cancer Therapeutics in Global Market
Table 5. Top Lung Cancer Therapeutics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Lung Cancer Therapeutics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Lung Cancer Therapeutics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Lung Cancer Therapeutics Product Type
Table 9. List of Global Tier 1 Lung Cancer Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Lung Cancer Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Lung Cancer Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Lung Cancer Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Lung Cancer Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Lung Cancer Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Lung Cancer Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Lung Cancer Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Lung Cancer Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Lung Cancer Therapeutics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Lung Cancer Therapeutics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Lung Cancer Therapeutics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Lung Cancer Therapeutics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Lung Cancer Therapeutics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Lung Cancer Therapeutics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Lung Cancer Therapeutics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Lung Cancer Therapeutics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Lung Cancer Therapeutics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Lung Cancer Therapeutics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Lung Cancer Therapeutics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Lung Cancer Therapeutics Revenue, (US$, Mn), 2023-2028
Table 30. AstraZeneca Corporate Summary
Table 31. AstraZeneca Lung Cancer Therapeutics Product Offerings
Table 32. AstraZeneca Lung Cancer Therapeutics Revenue (US$, Mn), (2017-2022)
Table 33. Eli Lilly and Company Corporate Summary
Table 34. Eli Lilly and Company Lung Cancer Therapeutics Product Offerings
Table 35. Eli Lilly and Company Lung Cancer Therapeutics Revenue (US$, Mn), (2017-2022)
Table 36. GlaxoSmithKline Corporate Summary
Table 37. GlaxoSmithKline Lung Cancer Therapeutics Product Offerings
Table 38. GlaxoSmithKline Lung Cancer Therapeutics Revenue (US$, Mn), (2017-2022)
Table 39. Roche Corporate Summary
Table 40. Roche Lung Cancer Therapeutics Product Offerings
Table 41. Roche Lung Cancer Therapeutics Revenue (US$, Mn), (2017-2022)
Table 42. Boehringer Ingelheim GmbH Corporate Summary
Table 43. Boehringer Ingelheim GmbH Lung Cancer Therapeutics Product Offerings
Table 44. Boehringer Ingelheim GmbH Lung Cancer Therapeutics Revenue (US$, Mn), (2017-2022)
Table 45. Pfizer Corporate Summary
Table 46. Pfizer Lung Cancer Therapeutics Product Offerings
Table 47. Pfizer Lung Cancer Therapeutics Revenue (US$, Mn), (2017-2022)
Table 48. Sanofi S.A. Corporate Summary
Table 49. Sanofi S.A. Lung Cancer Therapeutics Product Offerings
Table 50. Sanofi S.A. Lung Cancer Therapeutics Revenue (US$, Mn), (2017-2022)
Table 51. Bristol-Myers Squibb Corporate Summary
Table 52. Bristol-Myers Squibb Lung Cancer Therapeutics Product Offerings
Table 53. Bristol-Myers Squibb Lung Cancer Therapeutics Revenue (US$, Mn), (2017-2022)
Table 54. Novartis Corporate Summary
Table 55. Novartis Lung Cancer Therapeutics Product Offerings
Table 56. Novartis Lung Cancer Therapeutics Revenue (US$, Mn), (2017-2022)
Table 57. Agennix AG Corporate Summary
Table 58. Agennix AG Lung Cancer Therapeutics Product Offerings
Table 59. Agennix AG Lung Cancer Therapeutics Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Lung Cancer Therapeutics Segment by Type in 2021
Figure 2. Lung Cancer Therapeutics Segment by Application in 2021
Figure 3. Global Lung Cancer Therapeutics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Lung Cancer Therapeutics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Lung Cancer Therapeutics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Lung Cancer Therapeutics Revenue in 2021
Figure 8. By Type - Global Lung Cancer Therapeutics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Lung Cancer Therapeutics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Lung Cancer Therapeutics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Lung Cancer Therapeutics Revenue Market Share, 2017-2028
Figure 12. US Lung Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Lung Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Lung Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Lung Cancer Therapeutics Revenue Market Share, 2017-2028
Figure 16. Germany Lung Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 17. France Lung Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Lung Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Lung Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Lung Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Lung Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Lung Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Lung Cancer Therapeutics Revenue Market Share, 2017-2028
Figure 24. China Lung Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Lung Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Lung Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Lung Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 28. India Lung Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Lung Cancer Therapeutics Revenue Market Share, 2017-2028
Figure 30. Brazil Lung Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Lung Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Lung Cancer Therapeutics Revenue Market Share, 2017-2028
Figure 33. Turkey Lung Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Lung Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Lung Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Lung Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 37. AstraZeneca Lung Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Eli Lilly and Company Lung Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. GlaxoSmithKline Lung Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Roche Lung Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Boehringer Ingelheim GmbH Lung Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Pfizer Lung Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Sanofi S.A. Lung Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Bristol-Myers Squibb Lung Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Novartis Lung Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Agennix AG Lung Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Industry Market Size
